Huadong Medicine Co., Ltd (SHE:000963)

Market Cap	48.93B -25.8%
Revenue (ttm)	44.06B +4.3%
Net Income	3.50B -1.8%
EPS	2.00 -1.7%
Shares Out	1.75B
PE Ratio	13.97
Forward PE	10.93
Dividend	0.93 (3.36%)
Ex-Dividend Date	Jun 10, 2026

Volume	9,049,172
Open	28.26
Previous Close	27.69
Day's Range	27.48 - 28.26
52-Week Range	27.51 - 47.36
Beta	0.12
Analysts	Buy
Price Target	47.12 (+68.89%)
Earnings Date	Aug 14, 2026

About Huadong Medicine

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. The company operates through Pharmaceutical Manufacturing, Pharmaceutical Distribution, Medical Aesthetics, and Industrial Microbiology segments. It offers Chinese medicine, immunosuppressive agents, endocrine, digestive system, antineoplastic, cardiovascular, antibiotic drugs, medical beauty field, and medical devices, as well as engages in pharmaceutical logistics and industrial microbiology a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 19,095
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000963

Financial Performance

In 2025, Huadong Medicine's revenue was 43.61 billion, an increase of 4.07% compared to the previous year's 41.91 billion. Earnings were 3.41 billion, a decrease of -2.78%.

Analyst Summary

According to 13 analysts, the average rating for 000963 stock is "Buy." The 12-month stock price target is ¥47.12, which is an increase of 68.89% from the latest price.

Price Target

¥47.12

(68.89% upside)

Analyst Consensus: Buy